Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Conditions:   Early-stage Breast Cancer;   Hormone Receptor Positive Breast Carcinoma;   Invasive Breast Cancer;   Stage II Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage III Breast Cancer Interventions:   Drug: Anastrozole;   Procedure: Therapeutic Conventional Surgery;   Biological: Trastuzumab Deruxtecan Sponsors:   Jonsson Comprehensive Cancer Center;   Translational Research in Oncology-U.S;   Daiichi Sankyo Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials